covid-nirmatrelvir-ritonavir-pediatric - Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12-17 years following SARS-CoV-2 Omicron infection: A target trial emulation

Analysis code for the study "Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12-17 years following SARS-CoV-2 Omicron infection: A target trial emulation"

- Stata
Published by IvanAuHKU almost 2 years ago